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Cell death and cancerBNIP3 (Bcl-2/adenovirus E1B Nineteen Kilodalton Interacting Protein) is a pro-cell death member of the Bcl-2
family of proteins. Its expression is induced by the transcription factor Hypoxia Inducible Factor-1 (HIF-1)
under conditions of low oxygen (hypoxia) and is found over expressed in hypoxic regions of many tumors.
When over expressed, BNIP3 induces cell death through induction of mitochondrial dysfunction that is
dependent on the presence of BNIP3's TM domain. Herein, we have determined that the SkOv3 ovarian cancer
cell line expresses a truncated BNIP3 protein, which results in the elimination of the transmembrane domain.
Truncation that eliminates all four domains of BNIP3 protein also inhibits hypoxia-induced cell death in
SkOv3, HEK293, U251 and MCF-7 cells. Three different mutations in a BNIP3 expression vector that lead to a
truncated BNIP3 protein, lacking TM domain only, or lacking CD, BH3, and TM domains resulted in inhibition
of hypoxia-induced cell death when transfected into HEK293 cells. We found that truncated BNIP3 failed to
associate with themitochondria and the truncated BNIP3 lacking all four domains can bind towild type BNIP3.
Taken together, truncation of BNIP3 could be a novel mechanism for cancer cells to avoid hypoxia-induced cell
death mediated by BNIP3 over expression.Biology, 675 McDermot Ave,
2051; fax: +1 204 787 2190.
on).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
The human BNIP (Bcl-2 E1B nineteen kDa interacting protein)
family of proteins contains 4 members; BNIP1, 2 and 3 and Nix
(BNIP3-like protein X) [1]. BNIP3 is the most well characterized
member of the family and was ﬁrst identiﬁed by its ability to bind the
adenovirus E1B 19 kDa, which has an anti-apoptotic function to
preserve host cell viability during viral infection [2]. The 194 amino
acid BNIP3 protein contains several deﬁned regions including a
C-terminal transmembrane domain (TM), a 19 amino acid con-
served domain (CD), a Bcl-2 homology 3 (BH3) domain, and a PEST
domain (high frequency of Pro, Glu, Ser, and Thr amino acids which
are associated with having high rates of proteasomal turnover) [3,4].
BNIP3 is expressed in brain and skeletal muscle under normal
conditions [1], but its function is unknown. In most other tissues,
BNIP3 expression is induced by hypoxia-inducible factor 1 (HIF-1)
under hypoxic conditions. HIF-1α binds directly to a HIF-1α
responsive element (HRE) in the BNIP3 promoter, and this binding
is required for activation of the promoter [5]. The BNIP3 promoter is
responsive to both hypoxia-induced HIF-1 expression and over-
expression of HIF-1 [6]. In addition to hypoxia, BNIP3 expression canalso be induced by HIF-1 activation stimulated by nitric oxide (NO)
and mediated by the Ras/MEK/ERK signaling [7].
BNIP3 was identiﬁed to induce a cell type speciﬁc necrotic,
apoptotic or autophagic-type cell death. Autophagy involves lyso-
somal-mediated degradation of proteins and cellular organelles and
literally translates to “eat oneself”. The molecular mechanisms
governing autophagic vesicles were discovered using Saccharomyces
cerevisiae as a model organism, and the involved genes are called Atg
(autophagy-related) genes [1]. Over expression of BNIP3 can also
induce autophagic cell death, measured by observation of autophagic
vacuoles by electron microscope (EM), and localization and proces-
sing of LC3 (a protein that is incorporated in autophagic membranes
upon formation) in epithelial derived cells, glioma cells and
ﬁbroblasts [8–10]. In addition, BNIP3-induced cell death is blocked
by an inhibitor of autophagy (3-MA), but not an inhibitor for
apoptosis (Z-VAD-fmk). Necrosis is usually considered a type of cell
death with no signs of apoptosis. It is often referred to as passive or
accidental, occurring due to severe cellular injury such as hypoxia
[11]. Most studies in epithelial derived cells, macrophages, cytotoxic T
cells, and neurons show that BNIP3-induced cell death lacks
cytochrome c release from the mitochondria, DNA fragmentation
and/or caspase activation which correlates with a necrotic-like cell
death [12–15]. The term apoptosis refers to a highly regulated,
conserved, energy-dependent cell death that leads to elimination of
the cells without activation of an inﬂammatory response [16]. Over
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potential, reactive oxygen species production, DNA condensation,
activation of Bax and Bak, and caspase activation, characteristic of an
apoptotic response [13,17,18].
When BNIP3 is over expressed or induced following a stress
stimuli in cells, it induces cell death [2]. It is clear that BNIP3 exerts its
action at the mitochondria, however the mechanism of BNIP3-
mediated cell death remains poorly deﬁned. The presence of the TM
domain of BNIP3 was shown to be essential for BNIP3-induced cell
death. BNIP3 interacts with Bcl-2 and Bcl-XL through its TM domain
and its N-terminus (amino acids 1–49) and blocks these proteins from
acting as anti-apoptotic proteins [19]. Deletion of the TM domain
blocks BNIP3's ability to associate with the mitochondrial membrane
and induce cell death [20]. When BNIP3 has mutation of the TM
domain that prevents homodimerization but retains mitochondrial
localization it still induces cell death, suggesting that homodimeriza-
tion is not required for BNIP3 function [21]. Structure analysis from
recent studies suggests that the BNIP3 TM domain alone can form ion
conducting pathways in the membrane and helps to explain its
mechanism of action in hypoxia-induced cell death [22]. Alternatively,
in isolated mitochondria BNIP3 induces mitochondrial permeability
transition via its carboxy terminal tail which may directly interact
with one of the components of the permeability transition pore or
with other mitochondrial proteins [21]. It was recently shown that
BNIP3 mediates mitochondrial dysfunction through activation of Bax
or Bak, which is independent of mitochondrial permeability pore
opening [18]. Taken together these results suggest that BNIP3 induces
mitochondrial dysfunction by several different mechanisms yet to be
fully elucidated but all require the presence of the TM domain within
BNIP3.
Herein, we show that truncated forms of BNIP3 that lack the CD,
BH3 and TM domains fail to localize to the mitochondria and induce
cell death. Furthermore, when truncated BNIP3 is expressed, it blocks
hypoxia-induced cell death in a dominant negative manner and
interacts with wild-type BNIP3. This provides evidence that trunca-
tion of BNIP3 could lead to resistance to hypoxia-induced cell death.
2. Materials and methods
2.1. Tissue culture
All cell linesweremaintained in a humidiﬁed 5%CO2 environment at
37 °C. Human embryonic kidney (HEK) 293 and U251 cells were grown
in Dulbecco's modiﬁed Eagle's medium (DMEM; Gibco) supplemented
with 10% (v/v) bovine calf serum (BCS; Gibco), 1% (v/v) penicillin/
streptomycin, 100 U/ml and 100 μg/ml respectively (Gibco 15140-122).
MCF-7 breast cancer cell lines were grown in α-Modiﬁed Eagle's
medium (α-MEM; Gibco) supplemented with 10% (v/v) fetal bovine
serum (FBS; Gibco), 1% (v/v) each of 100 mMsodium pyruvate (Gibco),
1 M Hepes (Gibco), and penicillin/streptomycin. MCF-7 cells stably
expressing plasmids also contained 5 μg/ml Geneticin (Gibco 11811-
031). SkOv3 ovarian cells were grown in RPMI (Gibco) supplemented
with 10% (v/v) fetal calf serum, 100 U/ml penicillin and 100 μg/ml
streptomycin.
2.2. Western blotting
U251 cells were lysed for total protein or nuclear proteins as
previously published [23]. The lysates (60 μg) were separated by SDS-
PAGE and transferred to nitrocellulose membranes. Membranes were
blocked in 5% skim milk and Western blotted with antibodies against;
BNIP3 (monoclonal 1:1000,polyclonal1:200), Glut-1 (1:250,Medicorp)
or β-actin (1:50, Sigma). The membranes were washed three times for
5 min each in 1× TBST and incubated in the secondary antibody,
Horseradish peroxidase (HRP) conjugated goat α rabbit (1:2000, Bio-Rad). The Western blots were visualized with chemiluminescence
(NEN-Dupont).
2.3. Cell death assays
2.3.1. Acridine orange
MCF-7, MCF-7 PEST and SkOv3 cells were plated a minimum of
24 h before being placed in the Forma Scientiﬁc Anaerobic System
(hypoxic chamber), which maintains a ≤1% oxygen level. Total cell
death was assayed after 0, 24, 48 and 72 h of hypoxia treatment by
acridine orange–ethidium bromide (Sigma and Bio-Rad, respectively;
100 μg/ml each) staining. The number of dead cells (permeable to the
dye) was counted, and a minimum of 200 cells was counted per
sample.
2.3.2. β-galactosidase viability assay
U87 and U251 cells were co-transfected in 100 mm culture plates
with 2 μg of pCDNA3, pCDNA3-BNIP3, pCDNA3-BNIP3ΔTM, pCDNA3-
PEST mut BNIP3 plasmid DNA and 0.5 μg of β-galactosidase reporter
plasmid DNA. Transfected cells were incubated under normoxic
conditions for 24 h and hypoxic conditions for 48 h. Cells were ﬁxed in
0.2 % glutaraldehyde in 0.1 M PBS for 10 min and washed three times
with 0.1 M PBS, then stained in X-gal buffer (0.5 mg/ml 5-bromo-4-
chloro-3-indolyl-β-galactopyranoside, 3 mM K3Fe(CN)6, 3 mM K4Fe
(CN)6·3H2O, and 1 mM MgCl2 in 0.1 M PBS) at 37 °C for 24 h. The
percentage of dead cells was calculated by assessing the number of
rounded, condensed, blue-staining cells in the total population of
ﬂat, blue-staining cells. At least 200 cells were counted for each
experiment.
2.3.3. Counting viability of transfected cells
HEK293 cells and MCF-7 were transfected with HA-tagged
pcDNA3 (empty vector), TM mutant (positive control), PEST mutant,
and Δ261, Δ397 and Δ409 mutant vectors using Lipofectamine 2000
and gene porter respectively. The cells were cultured under hypoxic
conditions (b1% oxygen) or normoxic conditions for 48 h, after which
time the cells were cytospun onto slides and ﬁxed for immunoﬂuo-
rescent staining. DNA was stained with DAPI using Slowfade Gold
mounting reagent. Cells positive for mutant BNIP3 were determined
using polyclonal antibodies against BNIP3. Nuclear morphology in
transfected cells was used to determine viability, with a total of 200
cells counted per sample. These results represent 3 independent
experiments.
2.3.4. MTT cell viability assay
Equal numbers of cells were plated and then incubated under
normoxic or hypoxic conditions for 48 h.MTT (3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) reagent was added and the
cells were incubated for a further 4 h at 37 °C. Plates were then spun
down, the supernatant was removed and DMSO added to solubilize the
purple formazan that is formed in living cells. Plates were read on a
Titertek multiscan plate reader at 540 nm.
2.4. Localization of BNIP3 to the mitochondria
HEK293 cells were grown on cover slips in 6-well dishes and
transiently transfected with vectors expressing wild type or mutant
BNIP3 constructs. All of the vectors, excluding BNIP3 Δ236, contained
a 5′ hemaglutinin (HA) epitope tag. Transfections were carried out
with Lipofectamine 2000 reagent (Invitrogen) using 1.5 μg of DNA per
well and 12 μl of transfection reagent. The cells were incubated for
48 h post transfection before the addition of 0.3 μg/ml of Mitotracker
Red (Molecular Probes) suspended in dimethyl sulfoxide (DMSO,
Fisher). The cells were incubated for 1 h to allow for the uptake of the
Mitotracker Red before being ﬁxed in 3.7% formaldehyde in 1× PBS for
a minimum of 1 h at room temperature. The cells were washed 3
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(Sigma). Non-speciﬁc antibody bindingwas blocked by incubating the
cells in 10% FBS/1×PBS/0.1% Ipegal for 1 h at room temperature. The
primary antibody used was anti-HA tag 1/100 for all constructs
excluding BNIP3Δ236, which was probed with anti-BNIP3 polyclonal
antibody at a dilution of 1/750, for 2 h at room temperature. The cells
were washed as previously described and incubated with the
secondary antibody, anti-rabbit IgG ﬂuorescein isothiocyanate
(FITC) conjugate (Sigma), 1/500 for 1 h at room temperature. The
cells were washed and the slips mounted onto slides with 5 μl of
Slowfade Gold with DAPI (Invitrogen). The staining was visualized by
confocal microscopy.
2.5. Immunohistochemical staining of tumors
Slides containing 5 μm sections of mouse tumors were prepared by
the Manitoba Breast Tumor Bank. The slides were deparafﬁnized and
rehydrated as previously described [24]. The slides were washed once
for 5 min in ddH2O, followed by two washes of 5 min each in 1× PBS.
Endogenous peroxidase activity was blocked by incubating the slides in
freshly prepared 0.3 % H2O2 (Fisher) solution in methanol for 10 min.
The slides were blocked in 1× Roche blocking buffer (Roche) for 2 h at
room temperature in a humidity chamber. The primary antibody, anti-
BNIP3 (1/500) or anti-hypoxyprobe 1 (Chemicon International, 1/50),
was incubated with the slides overnight at 4 °C. The slides were
incubatedwith secondary antibody, biotinylated anti-rabbit IgG (Vector
Laboratories) or biotinylated anti-mouse IgG, respectively, at a
concentration of 1/1000 for 1 h at room temperature in a humidity
chamber. The slides were incubated with ABC reagent (Vector
Laboratories) for 30 min (prepared by adding one drop of solution A
to 2.5 ml of 1× PBS, followed by the addition of one drop of solution B,
mixed and incubated 30 min at room temperature before use). The
slides were incubated with DAB (Vector Laboratories) prepared by
mixing 1 drop of buffer solution, 2 drops of DAB stock solution, and 1
drop of H2O2 solution to 2.5 ml distilled water for 2 min 30 s. The slides
werewashed inwater for 5 min to stop the reaction. Slideswere stained
with Hematoxylin (Sigma) for 30 s, followed bywashing in running tap
water for 5 min and incubated in ddH2O for 5 min. The slides were
dehydrated by successive washing in 50%, 75%, 85%, 95%, 100%, and
100% ethanol for 2 min each followed by 2 washes in xylene. The slides
were mounted with Permount (Fisher).
2.6. Immunostaining and microscopy
Immunostaining was completed and HEK293, SkOv3 and U251
were grown under either normoxic (N) or hypoxic (H) conditions for
48 h. The cells were then ﬁxedwith 3.7% formaldehyde in 1× PBS at RT
for 1 h. Following three washes with 1× PBS (0.1% NP40), slides were
incubated with primary BNIP3 antibody (1:700 dilution in 10× FBS,
1× PBS, 0.1% NP40) for 1 h at RT. The slides were then washed three
times in PBS (0.1% NP40) and incubated with goat anti-rabbit
ﬂuorescein isothiocyanate (FITC)-conjugated secondary antibody
(Sigma) for 1 h. After three more washes, slides were mounted with
coverslips containing Vectashield mounting media with Hoescht dye
(to counter-stain for nuclei). 200 or more cells were counted per
sample to assess DNA condensation. Fluorescence was visualized and
captured using an Olympus BX51 ﬂuorescent microscope with a
Photometrics Cool Snap CF camera and an Olympus IX70 inverted
confocal laser microscope using Fluoview 2.0 software.
3. Results
3.1. SkOv3 cells express a truncated BNIP3 protein
BNIP3 protein expressionwas evaluated by bothWestern blotting
and immunoﬂuorescent staining in HEK293 and SkOv3 to determinewhether these cells express wild-type BNIP3 when subjected to
hypoxic conditions. Western blotting was completed using a
polyclonal antibody raised against the N-terminal portion of BNIP3
and a monoclonal antibody that recognizes the conserved domain
(CD) of BNIP3. In Western blot and immunoﬂuorescence experi-
ments, HEK293 cells failed express any detectible BNIP3 under
normoxic conditions, but endogenous BNIP3 expression can be
induced by incubating the cells under hypoxia (Fig. 1). Increased
expression of BNIP3 was detected in HEK293 cells after 48 h of
hypoxia. BNIP3 protein also showed both the 30 kDa band represent-
ing a monomer and 60 kDa band representing a dimer and detected
by a monoclonal antibody that recognizes the CD domain. In SkOv3
cells grown under normoxic conditions, the appearance of a 40 kDa
band was detected whereas the 30 kDa and 60 kDa bands failed to be
detected using the antibody that recognizes the N-terminal regions
of BNIP3 (Fig. 1A). This 40 kDa band was shown to be speciﬁc for
BNIP3 by competing out the signal by pre-incubation of the antibody
with recombinant BNIP3 protein (data not shown). In contrast, when
lysates from SkOv3 cells subjected to a time course of hypoxia were
Western blotted with the monoclonal BNIP3 antibody that recog-
nizes the CD domain, there was no protein detected, suggesting that
there is a truncation in the BNIP3 protein before the CD domain
(Fig. 1B). We conﬁrmed the expression of BNIP3 protein in SkOv3
cells grown under normoxic conditions by immunoﬂuorescencewith
the polyclonal antibody that recognizes the N-terminus of BNIP3.
Under normoxic conditions the N-terminal portion of the BNIP3
protein was detected in SkOv3 cells but not in HEK293 cells as
expected, whereas under hypoxic conditions, we observe BNIP3
expression in both cell lines, respectively (Fig. 1C). BNIP3 expression
in SkOV3 cells however, does not co-localize with the mitochondrial
stain Mitotracker, which conﬁrms that truncated BNIP3 proteins fail
to localize to the mitochondria. (Fig. 1D). This indicates that
truncated BNIP3 is expressed in SkOv3 that fails to localize to the
mitochondria.
3.2. Cells expressing truncated BNIP3 are resistant to hypoxia-induced
cell death
BNIP3 expression is induced by the transcription factor, HIF-1
under hypoxic conditions [6]. Since BNIP3 induces cell death via its
TM domain, we evaluated the effect that truncated BNIP3 expression
had on hypoxia-induced cell death in cell lines expressing the wild-
type protein. The truncated BNIP3 construct contained an insertion of
an adenosine at nucleotide 236 which leads to a truncated protein
lacking part of the PEST domain, and all of the TM domain, CD domain
and BH3 domain. This results in the elimination of these four BNIP3
domains. We used MCF-7 cells which express wild type BNIP3 under
hypoxic conditions, SkOv3 cells that express a truncated BNIP3
protein and an MCF-7 cell line stably over-expressing truncated
BNIP3. The cells were grown under hypoxic conditions (less that 1%
oxygen) for a time course of 24, 48 and 72 h. Cell death was
determined by the permeability of the cells to acridine orange–
ethidium bromide staining. We found that cells expressing truncated
form of BNIP3 were signiﬁcantly more resistant to hypoxia-induced
cell death compared to cells expressing wild type BNIP3. At 72 h of
hypoxia, 42% of MCF-7 cells underwent cell death, compared to the
18% cell death in the SkOv3 cells and 10% cell death in the MCF-7 cells
expressing truncated BNIP3 (Fig. 2A). Cell viability was also measured
using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay. We found that HEK293 cells have reduce cell
viability after 48 h of hypoxia while SkOv3 cells failed to show a
decrease in cell viability (Fig. 2B). To conﬁrm that the cells were
responding to hypoxia, we alsoWestern blotted for Glut-1 expression,
which is a marker of hypoxia. We show an increase in Glut-1
expression over time (Fig. 2C) indicating that the SkOv3 cells are
indeed responding to the hypoxic environment by up-regulating a
Fig. 1. SkOv3 cells express truncated BNIP3 protein. A) HEK293 and SkOv3 were grown under either normoxic (N) or hypoxic (H) conditions for 48 h. The cells were lysed and the
proteins Western blotted using a polyclonal BNIP3 antibody. The band that appears at 60 kDa in the HEK293 cells grown under hypoxia is speciﬁc and represents a wild type BNIP3
dimer. The 60 kDa band seen in the HEK293 cells is missing from the SkOv3 cells, but an additional band at 40 kDa appears. This band is speciﬁc and likely represents a dimer
of mutant BNIP3. The blots were stripped and reprobed for β-actin expression as a loading control. B) HEK293 and SkOv3 were grown under hypoxic conditions for a time course of
0–72 h. Cells were lysed and Western blotted as described in A). Actin was used as a loading control. C) HEK293 and SkOv3 cells were grown for 48 h under normoxic or hypoxic
conditions. The cells were then ﬁxed and probed with a BNIP3 rabbit polyclonal antibody that recognizes an N-terminal portion of the protein. A FITC (green) conjugated anti-rabbit
secondary antibody was used to detect the BNIP3 antibody indicating the presence of BNIP3 protein. D) SkOv3 cells were stained with Mitotracker (mitochondrial stain, green) and
with antibodies against BNIP3 (red). The cells were analyzed on a ﬂuorescence microscope. These results represent three independent experiments.
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death when compared to the MCF-7 cells expressing wild type BNIP3.
Indeed, SkOv3 cells failed to up-regulated BNIP3 during hypoxia(Fig. 1) but MCF-7 cells signiﬁcantly increased BNIP3 under hypoxia
(Fig. 2D). Taken together, this suggests that truncated BNIP3 blocks
hypoxia induced cell death.
Fig. 2. Cells expressing PEST mutant BNIP3 are resistant to hypoxia-induced cell death. A) MCF-7, SkOv3 and MCF-7 cells stably expressing truncated BNIP3 (PEST) were cultured
under hypoxic conditions for a time course of 24, 48 and 72 h. Following hypoxic treatment cell deathwas determined bymembrane permeabilization using acridine orange staining.
A minimum of 200 cells was counted per sample. These results represent a minimum of 3 independent experiments. B) HEK 293 and SkOv3 cells were placed under normoxia or
hypoxia for 48 h. Cell viability was measured using a MTT assay. Standard error represented three repeated experiments. C) SkOv3 cell lysates were assayed for Glut-1 expression by
Western blot. The blots were stripped and re-probed for β-actin as loading control. D) MCF-7 cells were placed under hypoxia for a 72 hour time course. The cells were lysed and
Western blotted for BNIP3. Loading control was actin expression levels. E) SkOv3 cells growing on coverslips were transiently transfected with HA-tagged wild type BNIP3 or empty
vector (pcDNA3) using Lipofectamine 2000. The cells were cultured under normoxic conditions for 24 h before being ﬁxed and immunoﬂuorescence detection of the HA tag. DNA
was stained with DAPI and nuclear morphology was used to determine the viability of positively transfected cells. A minimum of 200 cells was counted per sample. These results
represent 3 independent experiments.
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cells
The major function of wild type BNIP3 is to induce cell death [25].
Since SkOv3 cells expressing truncated BNIP3 are resistant to hypoxia-
induced cell death, we sought to determine whether over expression
of wild type BNIP3 is able to induce cell death. The cells were
transiently transfected with an HA-tagged wild type BNIP3 construct
and pcDNA3 (empty vector) for transfection control. Twenty four
hours post transfection the cells, grown on cover slips, were ﬁxed and
stained for the HA-tag indicating the positive transfection of the cell
with wild type BNIP3. Positively stained cells were then assessed for
viability based on nuclear morphology. When wt BNIP3 was
transfected into SkOv3 cells, 55% of SkOv3 cells transfected with
wild type BNIP3 underwent cell death 24 h after transfection,
compared to less than 10% cell death in the vector alone control
cells (Fig. 2E). This conﬁrms that wild type BNIP3 is able to induce cell
death under normoxic conditions, and that BNIP3 over expression
induces cell death in SkOv3 cells.3.4. HEK293 and MCF-7 cells transfected with different truncated forms
of BNIP3 are resistant to hypoxia-induced cell death
The transmembrane domain of the BNIP3 protein is essential for its
ability to dimerize and induce cell death [22]. It has previously been
shown that a BNIP3 lacking its TM domain is able to inhibit hypoxia-
induced cell death in a dominant negative fashion [5,23]. To
determine if truncated BNIP3 lacking all four domains is also able to
inhibit hypoxia-induced cell death similarly to BNIP3 lacking only the
TM domain, HEK293, MCF-7 (breast cancer cell line) and U251
(glioma cell line) cells were transfected with pcDNA3 (empty vector),
BNIP3 lacking the TM domain (TM) or truncated BNIP3 (PEST). The
cells were cultured under hypoxic conditions (b1% oxygen) for 48 h,
after which the cells were cytospun onto slides and ﬁxed for
immunoﬂourescence. Nuclear morphology was used to determine
viability in positively transfected cells. HEK293 cells transfected with
pcDNA, TM and PEST constructs underwent 28%, 22% and 17% cell
death respectively (Fig. 3A). Similarly, MCF-7 cells exhibited 30%, 17%
and 17% cell death when transfected with empty vector, TM and PEST
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death when transfected with empty vector and PEST constructs
respectively (Fig. 3A, B). These results indicate that cells expressingtruncated BNIP3 were resistant to hypoxia-induced cell death when
compared with cells expressing an empty vector control. Expectedly,
truncated BNIP3 did not induce cell death when over expressed in
normoxic cells compared to wt BNIP3 (Fig. 3C). To conﬁrm that the
various truncated forms of BNIP3 are expressed under transient
transfection condition, we Western blotted for BNIP3 using both the
monoclonal (detects only BNIP3 and ΔTM) and polyclonal antibodies
(detects all truncated forms of BNIP3). We found that PEST, truncated,
ΔTM and wild type BNIP3 are expressed in HEK 293 cells (Fig. 3D).
Overall, this increased resistance supports the hypothesis that
truncated BNIP3 is able to block the function of wild type BNIP3 and
may act in a dominant negative fashion.
3.5. Different BNIP3 truncations inhibit hypoxia-induced cell death in a
dominant negative fashion
Cells expressing either BNIP3 lacking the TM domain or lacking all
four domains were resistant to hypoxia-induced cell death [5,23]. To
determine whether other truncations lead to a resistance to hypoxia-
induced cell death, we created three different truncated BNIP3
constructs, Δ261 (contains only the PEST domain), Δ397 (contains
PEST, CD, and BH3 domains) and Δ409 (lack only TM domain)
(Fig. 4A). Hypoxia treatment induces the expression of endogenous
wild type BNIP3 protein in HEK293 cells therefore, cells transfected
with truncated forms of BNIP3 and exposed to hypoxia would express
both wild type and truncated proteins. HEK293 cells were transiently
transfected with Δ261, Δ397, Δ409 and pcDNA (empty vector) and
cultured under normoxic or hypoxic conditions for 48 h. The cells
were then ﬁxed and immunoﬂuorescently stained for positively
transfected cells (Fig. 4B). Nuclear morphology was assayed to
determine cell viability. Cells transfected with pcDNA3, Δ261, Δ397
and Δ409 underwent 40%, 22%, 29% and 26% cell death respectively
(Fig. 4C) indicating the truncated BNIP3 functions to block hypoxia-
induced cell death.
3.6. Truncated BNIP3 does not localize to the mitochondrial membrane
The transmembrane domain of BNIP3 is essential for its ability to
integrate into the mitochondrial membrane [22]. When cells are
subjected to hypoxia BNIP3 localizes to the mitochondria, shown by
co-staining with Mitotracker (Fig. 5A). We wanted to conﬁrm that
truncated BNIP3 proteins fail to localize to the mitochondria. HEK293
cells were transiently transfected with truncated BNIP3 constructs
(Δ261, Δ397 and Δ409) or pcDNA (empty vector) and cultured under
normoxic conditions for 48 h. Mitotracker Red, which is a dye taken
up by the mitochondria, was added to the cells 30 min prior toFig. 3. Expression of truncated BNIP3 fails to induce cell death and HEK293, MCF-7 and
U251 cells transfected with truncated BNIP3 were resistant to hypoxia-induced cell
death. A) HEK293 and MCF-7 cells were transfected with pcDNA3 (empty vector),
BNIP3 lacking TM domain (TM), and BNIP3 lacking all four domains (PEST) using
Lipofectamine 2000 and gene porter respectively. The cells were cultured under
hypoxic conditions (b1% oxygen) for 48 h, after which time the cells were cytospun
onto slides and ﬁxed for immunoﬂourescent staining. Cells positive for mutant BNIP3
were determined using polyclonal antibodies against BNIP3. Nuclear morphology was
used to determine viability, with a total of 200 cells counted per sample. B) U251 cells
were transfected with cDNA for truncated BNIP3 or empty vector (control) in combi-
nation with a β-gal expression vector. The cells were placed under hypoxic conditions
for 72 h and the amount of cell deathwas determined in cells expressingβ-galactosidase
as described in the Materials and methods section. Normoxia represents the amount of
cell death in U251 cells transfected with empty vector under normal oxidative
conditions. C) U251 cells were transfected with cDNA for truncated BNIP3 or empty
vector (control) in combination with a β-gal expression vector. Cell death was
determined as above. Error bars represent the standard error determined from three
independent experiments. * denotes a p value b0.001 representing statistical
signiﬁcance between empty vector (control) transfected cells and cells transfected
with truncated BNIP3 under hypoxia. D)HEK 293 cellswere transiently transfectedwith
expression vectors containing the cDNA for PEST, truncated, ΔTM and wild type BNIP3.
The lysate was Western blotted with i) monoclonal antibody against CD domain of
BNIP3 or ii–iii) a polyclonal antibody against the N-terminal domain.
Fig. 4. HEK293 cells transfected with different BNIP3 truncations are more resistant to hypoxia-induced cell death in a dominant negative fashion. A) Schematic diagram of the
different truncated BNIP3 proteins created. B) HEK293 cells were transfected with HA-tagged pcDNA3 (empty vector), Δ261, Δ397 and Δ409 vectors using Lipofectamine 2000. Cells
positive for mutant BNIP3 were determined using polyclonal antibodies against the HA tag (green). Nuclei were counterstained with DAPI (blue). C) HEK293 cells were transfected
with HA-tagged pcDNA3 (empty vector), Δ261, Δ397 and Δ409 mutant vectors. The cells were cultured under hypoxic conditions (b1% oxygen) or normoxic conditions for 48 h,
after which time the cells were cytospun onto slides and ﬁxed for immunoﬂourescent staining. Cells positive for mutant BNIP3 were assayed for viability by visualization nuclear
morphology, with a total of 200 cells counted per sample.
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rescence. Visualization of BNIP3 localization was performed using the
confocal microscope. In Fig. 5B, all truncated BNIP3 proteins failed to
localize to the mitochondria (Fig. 5B).
3.7. Wild type BNIP3 binds to a His-tagged truncated BNIP3 in vitro
Previous studies have shown that BNIP3 dimerizes and these
dimers associate with the mitochondria [19]. BNIP3 association with
Bcl-2 blocks its localization to the mitochondria and its induction of
cell death [19]. We wanted to determine whether truncated BNIP3
(lacking all four domains) acts as a dominant negative protein by
interacting with wild-type BNIP3.We transfected U87 cells with wild-
type BNIP3 or vector alone and the lyates were immunoprecipitated
through a nickel-agarose column with a bound His-tagged truncated
BNIP3 protein (Fig. 6). We found that wild-type BNIP3 bound to the
His-tagged truncated BNIP3 but not the ni-agarose beads alone,indicating that wild-type and truncated BNIP3 forms heterodimers.
This ability to heterodimerize suggests that it affects the ability of wild
type BNIP3 to localize to the mitochondria.
4. Discussion
BNIP3 is an important cell death protein that induces death in
response to cellular stresses such as hypoxia. Hypoxia in tumors is
associated with metastasis and poor prognosis, and is an important
predictive indicator of therapeutic response. Cells within hypoxic
regions often become resistant to chemotherapeutic agents and
radiation therapy [26,27]. Hypoxic cells are considered to be resistant
to most anticancer drugs for several reasons: (1) hypoxic cells are
distant from blood vessels, and as a result are not adequately exposed
to the drug; (2) hypoxia can induce a decrease in cellular proliferation;
(3) hypoxia often selects cells with reduced apoptotic potential; (4) the
cytotoxicity of DNA lesions caused by some anticancer drugs is
Fig. 5. Truncated BNIP3 is unable to localize to the mitochondrial membrane. A) U251 cells were placed under normoxic or hypoxic conditions for 48 h. The cells were stained with
Mitotracker (mitochondrial stain, green) and with antibodies against BNIP3 (red). The cells were analyzed on a confocal microscope. These results represent three independent
experiments. Yellow staining represents co-localization of BNIP3 and the mitochondria. B) HEK293 cells were transfected with HA-tagged pcDNA3 (empty vector), Δ261, Δ397 and
Δ409 mutant vectors using Lipofectamine 2000. The cells were cultured under normoxic conditions for 48 h. Mitotracker Red was added to the cells 30 min before the cells were
cytospun onto slides and ﬁxed for immunoﬂourescent staining. Cells positive for mutant BNIP3 were determined using polyclonal antibodies against the HA tag.
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involved in drug resistance [28]. HIF-1 is central to most hypoxia
responses, and as such, inhibition of HIF-1 activity may be important in
combinatory cancer therapy [29]. BNIP3 is a potential mediator of cell
death during ischemia in cardiac, hepatocyte and neuronal cells.
Blocking its function may be important in reducing the amount of
tissue loss during both stroke and ischemic heart disease or congestive
heart failure [30–32]. In cancer, activatingBNIP3-induced cell deathmay
be important in tumorswith loss of BNIP3due tomutation,methylation,
histone deacetylation or nuclear localization [23,33,34].
BNIP3-induced cell death is blocked bymultiple mechanisms. BNIP3
is expressed in skeletal muscle cells under normal conditions, but is
sequestered away from the mitochondria by unknown mechanisms,which leads to blockage of BNIP3-induced cell death [3,23]. BNIP3-
induced cell death is inhibited by EGF signaling in HEK293 and MCF-7
cells, through ERK1/2, mediated by the CD domain of BNIP3, but the
mechanism for this is unknown as well [5]. This mechanism could be
exploited by tumors to reduce tumor cell death by blocking BNIP3
function. Increased expression of epidermal growth factor receptor
(EGFR) is found inmany tumor types, and treating cancer cellswith EGF
blocks BNIP3 induced cell death [5]. In addition, previous studies from
our laboratory have identiﬁed that BNIP3 is expressed in glioma cells
and NHA in normal conditions primarily in the nucleus which blocks
BNIP3's ability to interact with the mitochondria and induce cell death
[23].When BNIP3 is localized to the nucleus it is sequestered away from
the mitochondria and can no longer induce cell death. Tumor cells may
Fig. 6. Endogenous wt BNIP3 binds in vitro to a His-tagged truncated BNIP3. His-tagged
236insA BNIP3 (truncated BNIP3 lacking all four domains) was bound to nickel agarose
beads and HEK293 cells transfected with vector alone or wt BNIP3 were lysed and
added to these beads. The beads were washed with 250 mM imidazole and the
resulting elution was Western blotted for wt BNIP3. As a negative control, beads alone
were incubated with lysate expressing wt BNIP3. Lysate expressing wt BNIP3 was used
as a positive control. The blots were stripped and reprobed with anti-His tag antibodies.
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survival advantage [25].
The presence of truncated BNIP3 proteins could be another
mechanism to explain why BNIP3 is expressed in tumors, but cells
remain viable. We have identiﬁed that the ovarian cancer cell line
SkOv3 expresses a truncated form of BNIP3 that does not contain the
transmembrane domain. The transmembrane domain of BNIP3 is
essential for its ability to integrate into the mitochondrial membrane
and induce cell death. BNIP3 is found to contribute to hypoxia-
induced cell death that is negated by expression of truncated BNIP3
constructs such as BNIP3 lacking the TM domain in HEK293 cells, and
U251 and U87 glioma cell lines [5,23]. This suggests that the truncated
BNIP3 protein can act as a dominant negative binding to wild-type
BNIP3 and block its interaction with the mitochondria. We have
shown that BNIP3 truncations lacking all four domains fail to localize
to the mitochondrial membrane and induce cell death when
transfected into HEK293 cells. Cells expressing all truncated BNIP3
constructs are resistant to hypoxia-induced cell death. Truncated
BNIP3 may inhibit wild type BNIP3 by competing with regulatory
factor(s) required for mitochondrial targeting, or by directly prevent-
ing wild type BNIP3 from inducing cell death, perhaps by forming
(inactive) heterodimers that cannot integrate within the mitochon-
drial outer membrane. We found that wild-type BNIP3 binds to
truncated BNIP3. This could be due to changes in conformation of
truncated BNIP3 to permit its binding to full length BNIP3 and this
binding could still involve the transmembrane domain in wild type
BNIP3. In the future, protein binding kinetic studies of the truncated
proteins will increase our understanding the dominant-negative
effects observed. In addition, the involvement of other proteins
binding to truncated BNIP3 could also affect its function in blocking
hypoxia induced cell death. This will be the focus of future
investigation. Nevertheless, heterodimers of wild type and truncated
BNIP3 could prevent mitochondrial localization and cell death.
5. Conclusions
Our results demonstrate that truncated BNIP3 inhibits hypoxia-
induced cell death. The presence of a truncated BNIP3 protein in the
ovarian cell line implies that truncated BNIP3 may provide an
advantage for these cells under stress conditions such as hypoxia
and chemotherapeutic drug treatment. It would be important to
determine whether truncation of BNIP3 occurs in solid tumors and if
this truncation contributes to cell survival. Furthermore, the mech-
anism for the truncations either through mutations or proteincleavage needs to be determined. In SkOv3 cells, the BNIP3 gene is
wild type (data not shown) suggesting non-genetic mechanism for
cleavage. This will be the focus of future investigations.
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